Results for MIS-C

CHOP and Penn researchers discussed the latest findings about the mechanisms of immunity at the CHOP Research Institute 2022 Scientific Symposium.

This week’s news roundup features CHOP’s Forbes’ ranking, a cancer research editorial by Madeline Bell, mask mandates, and mental disorders.

Learn about novel findings neuroblastoma, MIS-C, and more in this week's roundup of research news.

The findings were published in Nature Communications.

Learn about novel findings and new funding from our Children’s Hospital of Philadelphia researchers.

Children with MIS-C, a post-infectious complication of SARS-Co-V2, regained normal cardiac function within about three months of initial treatment.

Researchers used deep immune profiling to better understand immune activation in children with multisystem inflammatory syndrome.

Using deep immune profiling, CHOP researchers have found children with MIS-C are extremely immune activated.

CHOP researchers provide photos and descriptions of skin manifestations in MIS-C patients to aid healthcare providers diagnose future cases.

CHOP researchers describe different types of rashes they have seen in patients diagnosed with the COVID-19-related inflammatory syndrome.